Life Science Partnering
We recently had a chance to profile one of our presenting companies at the 2014 BioPharm America event later this month. Head over to the blog to find out more about the Broad Institute. http://www.partnering360.com/blog/2014/09/10/broad-institute-focus-on-cardiac-arrhythmia/
Today at the partnering 360 blog, we take a look at some of the companies who have recently entered into immuno-oncology partnerships: http://www.partnering360.com/blog/2014/08/26/immuno-oncology-market-deals-on-the-rise/
Check out the latest post at the partnering360 blog that highlights the Insights feature speaking with Robert Urban, leader at the Boston Innovation Center for Johnson & Johnson.
They're giving them funds. Why? Head over to the partnering360 blog to find out: http://www.partnering360.com/blog/2014/08/05/innovative-funding-for-small-and-medium-enterprises-in-europe/
The investment climate is excellent in 2014, and venture capital attendance at BioPharm America™ will be stronger than ever. Investment companies attending include Forbion Capital Partners; Atlas Venture; Teralys Capital; Sanofi-Genzyme BioVentures, Sanofi; MPM Capital; SR One; Third Rock Ventures; Broadview Ventures, Inc.; MS Ventures; Mitsui Global Investment; New Enterprise Associates; MP Healthcare Venture Management; New Leaf Venture Partners; Third Rock Ventures; and Fidelity Biosciences.
What will the financing environment look like through the end of 2014? Share your views here.
Registration info is available at http://www.ebdgroup.com/bpa/registration/index.php